Groundbreaking cancer trial to recruit patients within the NHS | The IndependentNotifications can be managed in browser preferences.Jump to contentIndependentIndependent Bulletin homepageSocial PartnerWe are 8 logo (opens in a new tab)AllNewsSportCultureLifestyleJane KirbyMonday 21 July 2025 07:55 BSTA new immunotherapy drug trial for glioblastoma is now recruiting patients in the NHS (PA)A new immunotherapy drug trial for glioblastoma, the deadliest form of brain cancer, is now recruiting patients in the NHS.The trial follows a previous study where patient Ben Trotman's tumour vanished, and he has shown no signs of the disease for over two years, a rare outcome for glioblastoma.The NHS study will enrol 16 patients over 18 months, who will receive the immunotherapy drug ipilimumab before standard treatment.The trial was established in memory of Baroness Margaret McDonagh, who died from the disease, and was funded by over £1 million raised by her sister, Dame Siobhain McDonagh MP.Led by Consultant Medical Oncologist Dr Paul Mulholland, the trial aims to build on previous findings and offers significant hope for patients with this aggressive cancer.In fullDad’s aggressive brain cancer vanishes after taking new drugThank you for registeringPlease refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in